Get the Stockscreener App
0.4175
11.57%
0.0433
After Hours:
.41
-0.0075
-1.80%
Beyond Air Inc stock is traded at $0.4175, with a volume of 3.52M.
It is up +11.57% in the last 24 hours and down -8.24% over the past month.
Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.
See More
Previous Close:
$0.3742
Open:
$0.4
24h Volume:
3.52M
Relative Volume:
3.11
Market Cap:
$30.14M
Revenue:
$1.78M
Net Income/Loss:
$-58.35M
P/E Ratio:
-0.2546
EPS:
-1.64
Net Cash Flow:
$-56.66M
1W Performance:
+7.88%
1M Performance:
-8.24%
6M Performance:
-25.45%
1Y Performance:
-70.07%
1-Day Range:
$0.3942
$0.4679
1-Week Range:
$0.34
$0.4679
52-Week Range:
$0.296
$2.17
Beyond Air Inc Stock (XAIR) Company Profile
Name
Beyond Air Inc
Sector
Industry
Phone
516-665-8200
Address
900 STEWART AVENUE, GARDEN CITY, NY
Compare XAIR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XAIR
Beyond Air Inc
|
0.4175 | 30.14M | 1.78M | -58.35M | -56.66M | -1.64 |
|
ABT
Abbott Laboratories
|
113.48 | 196.83B | 41.22B | 5.77B | 6.49B | 3.29 |
|
SYK
Stryker Corp
|
383.42 | 146.17B | 21.97B | 3.59B | 3.21B | 9.33 |
|
BSX
Boston Scientific Corp
|
98.66 | 145.41B | 15.91B | 1.79B | 1.89B | 1.21 |
|
MDT
Medtronic Plc
|
88.08 | 112.94B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
69.78 | 41.16B | 6.60B | 4.16B | 490.10M | 6.93 |
Beyond Air Inc Stock (XAIR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-25-24 | Downgrade | BTIG Research | Buy → Neutral |
| Jul-28-23 | Initiated | Piper Sandler | Overweight |
| Jun-15-23 | Initiated | BTIG Research | Buy |
| Apr-28-21 | Initiated | Truist | Buy |
| Oct-22-19 | Initiated | Oppenheimer | Outperform |
Beyond Air Inc Stock (XAIR) Latest News
Beyond Air Up 15%, Insiders Still Down After US$1.60m Purchase - Simply Wall St
Smith & Nephew (SNN) Stock Surges Amid Strong Financial Performa - GuruFocus.com
Financial Survey: Beyond Air (NASDAQ:XAIR) versus Perspective Therapeutics (NYSE:CATX) - Defense World
Insider Stock Buying Reaches US$1.60m On Beyond Air - Yahoo Finance
Does Beyond Air Inc (NASDAQ: XAIR) Still Need To Convince Analysts? - Stocks Register
Beyond Air to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025 - The Manila Times
Beyond Air CEO to Present at Lytham Partners 2025 Healthcare Investor Summit - StockTitan
State Street Corp Sells 53,700 Shares of Beyond Air, Inc. (NASDAQ:XAIR) - Defense World
Inhaled Nitric Oxide Delivery Systems Market Size to Hit USD 562.47 Bn by 2034 - Precedence Research
Beyond Air replaces auditor, cites no disagreements - Investing.com
Beyond Air's SWOT analysis: LungFit PH maker faces cash burn as stock seeks lift - Investing.com
CBS Releases First Look for New Daytime Soap Opera ‘Beyond the Gates’ (TV News Roundup) - Variety
Bears are Losing Control Over Beyond Air (XAIR), Here's Why It's a 'Buy' Now - MSN
Beyond Air's SWOT analysis: LungFit PH stock faces cash burn challenges - Investing.com
National Advertising Division Recommends Beyond Air Discontinue or Modify Comparative Safety Claims for its iNO Products - The Manila Times
National Advertising Division Recommends Beyond Air - GlobeNewswire
National Advertising Division Recommends Beyond Air Discontinue or Modify Comparative Safety Claims for its iNO Products - GlobeNewswire Inc.
LungFit PH receives European CE mark approval to treat newborns - Pulmonary Hypertension News
Beyond Cancer Announces Approval by the Israeli Ministry of Health to Conduct a Phase 1b Clinical Trial Utilizing Low Volume Ultra-High Concentration Nitric Oxide (LV UNO) in Combination with Anti-PD-1 Therapy - The Manila Times
Beyond Cancer Gets Green Light for Novel Cancer Immunotherapy Trial in Israel | XAIR Stock News - StockTitan
Beyond Air’s LungFit PH system gains European CE mark approval - Yahoo Finance
XAIR (Beyond Air) Shares Outstanding (EOP) : 72.19 Mil (As of Sep. 2024) - GuruFocus.com
Beyond Air Receives CE Mark in Europe for the LungFit® PH System - The Manila Times
Beyond Air Secures EU Approval for Breakthrough Nitric Oxide System, Unlocks $1M Milestone - StockTitan
Beyond Air (STU:48L) Shares Outstanding (EOP) : 72.19 Mil (As of Sep. 2024) - GuruFocus.com
Medical Device Player Beyond Air's Subsidiary Reveals Encouraging Data From Early-Stage Cancer Study - MSN
Discover Air Tahiti Nui's 'Tahitian Dreamliners' Connecting Bora Bora And Beyond - Simple Flying
Beyond Air expands stock option plan and authorizes shares By Investing.com - Investing.com Canada
Beyond Air expands stock option plan and authorizes shares - Investing.com India
Beyond Air Approves Key Changes at Annual Meeting - TipRanks
NeuroNOS Appoints Nobel Laureate, Roger D. Kornberg, to Scientific Advisory Board - The Manila Times
Nobel Laureate Roger Kornberg Joins NeuroNOS Advisory Board to Advance Autism Research - StockTitan
AiAdvertising Appoints Douglas Beck, CPA, as Chief Financial Officer - citybiz
AiAdvertising Announces CFO Transition in Preparation for Nasdaq Uplisting - Business Wire
AiAdvertising Appoints Douglas Beck as New CFO - TipRanks
32 Rules for Flying Now - Bloomberg
Beyond Air, Inc. (XAIR) Reports Q2 Loss, Lags Revenue Estimates - MSN
Beyond Air Stock Slides After Q2 Earnings Beat, Retail’s Confident - MSN
Beyond Air to Participate in the Piper Sandler 36th Annual Healthcare Conference - The Manila Times
Rocket Lab USA, Inc. (RKLB) Reports Q3 Loss, Tops Revenue Estimates - MSN
Beyond Air Reports Increased Revenue Amid Financial Challenges - TipRanks
Big Yellow Group downgraded to Hold from Buy at Jefferies - MSN
Beyond Air Inc (XAIR) Quarterly 10-Q Report - Quartz
Beyond Air, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024 - Marketscreener.com
Beyond Air, Inc. (NASDAQ:XAIR) Q2 2025 Earnings Call Transcript - Insider Monkey
Beyond Air® Reports Fiscal Second Quarter 2025 Financial Results and Provides Corporate Update - The Manila Times
Beyond Air earnings matched, revenue fell short of estimates By Investing.com - Investing.com Canada
Beyond Air (XAIR) Reports 60% Hospital Contract Growth, Secures $20.6M Funding | XAIR Stock News - StockTitan
Beyond Cancer Presents Promising Preclinical Data on Low Volume Ultra-High Concentration Nitric Oxide (LV UNO) Therapy at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting - Markets Insider
Beyond Cancer Presents Promising Preclinical Data on Low - GlobeNewswire
Beyond Air Inc Stock (XAIR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.25%
0.57%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):